It has not yet been investigated whether protection of liver cells from mitochondria-induced ROS via PGC-1α:ERα contributes to sex-dependent differences in human NASH pathogenesis, where pre-menopausal women are more resistant. The gene discussed is PPARGC1A; the disease is metabolic dysfunction-associated steatohepatitis.